Updated:
New York Medical College
New York Medical College was established in 1860 and joined the Touro University System in 2011, placing its endowment under the governance of a...
New York Medical College
New York Medical College was established in 1860 and joined the Touro University System in 2011, placing its endowment under the governance of a multi-institutional academic network. Joseph D. Mark, a former investment banker and venture capitalist, serves as Chair of the Board of Trustees, providing financial oversight. The college operates from a campus in Valhalla, New York, and trains students through its School of Medicine, Graduate School of Biomedical Sciences, and School of Health Sciences and Practice. The endowment is deployed as a fund-of-funds, with underlying allocations not publicly detailed. Real estate assets form a tangible component of the portfolio, including the primary campus at 40 Sunshine Cottage Road, a commercial building at 19 Skyline Drive, the BioInc@NYMC incubator at 7 Dana Road, and residential properties known as Grasslands I and II. Academic operations are anchored by the partnership with Westchester Medical Center, the college's primary clinical affiliate. The board of trustees guides investment policy alongside system-level administration from Touro, though specific staffing for the investment office is not publicly disclosed. A $3 million grant from the Norman E. Alexander Family M Foundation has recently supported campus development, and the college maintains professional memberships in the Association of American Medical Colleges and the Associated Medical Schools of New York. The endowment remains sized below $100 million, placing it among smaller institutional pools. NYMC's structure distinguishes it from a standalone single-family office or a purely independent endowment. Its integration into the Touro University System means investment governance is shared, and the presence of a former VC as board chair introduces venture-oriented thinking to a traditionally conservative fund-of-funds approach. The BioInc@NYMC facility further signals a willingness to bridge academic medicine with commercial life-science activity.
General information
Firm type
Endowment / Foundation
Year founded
1860
Location
Region
North America
Country
United States
City
Valhalla
Corporate office
Valhalla, New York, United States
Principals
Joseph D. Mark
Chair of the Board of Trustees
Sector focus
Frequently asked questions
Who runs investment decisions at New York Medical College?
The board of trustees, chaired by Joseph D. Mark, a former investment banker and venture capitalist, oversees the endowment. Day-to-day investment management details are not publicly disclosed, but the college is part of the Touro University System since 2011, which likely integrates system-level governance into asset allocation. The exact delegation of authority between the NYMC board and Touro's administration is not outlined in public documents.
How is the New York Medical College endowment invested?
The endowment follows a fund-of-funds strategy, meaning it allocates capital across multiple external managers rather than selecting individual securities or making direct investments. Asset-class specifics are not publicly reported. The portfolio also includes direct real estate assets in Valhalla, New York, such as campus buildings, a life-science incubator, and residential properties.
Is New York Medical College a single family office?
No. It is the endowment of a private medical school that has been a member of the Touro University System since 2011. While the board includes a chair with a private-investing background, the entity is an institutional asset owner supporting higher education and research, not a family office.
Which sectors does the New York Medical College endowment explicitly focus on?
The endowment's fund-of-funds approach does not restrict it to specific sector mandates, but the college's operations concentrate on healthcare services, biomedical education, and clinical research. Its wholly owned real estate portfolio is specific to the Valhalla campus and includes the BioInc@NYMC incubator, which houses early-stage life-science companies.
How is the New York Medical College endowment related to Touro University?
NYMC has been a member of the Touro University System since 2011. This means its endowment is part of a larger academic network, likely benefiting from shared administrative and investment governance resources. The relationship creates a layer of system-wide oversight on top of NYMC's own board of trustees.
Does the New York Medical College endowment co-invest with other institutions?
The endowment has been supported by targeted philanthropic capital, such as a $3 million grant from the Norman E. Alexander Family M Foundation for campus development, but no ongoing co-investment partnerships with external institutional investors are disclosed. Its investment activity is primarily conducted through fund commitments.
What is the governance structure for the endowment?
The Board of Trustees, led by Chair Joseph D. Mark, holds fiduciary responsibility. Mark's background includes investment banking and venture capital, which may influence the endowment's posture. As part of the Touro University System, the college operates under a combined governance model that includes system-level administration.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on endowments & foundations?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: